Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis
Renal prognosis in light-chain amyloidosis (AL) is determined by categorizing patients into three renal stages at diagnosis and assessing Renal Response or Renal Progression following chemotherapy after 6 months. We evaluated, in a test (N=1935) cohort of patients with renal AL amyloidosis who were...
Saved in:
| Main Authors: | Muhammad Umaid Rauf, Steven Law, Marisa Santostefano, Philip N. Hawkins, Aviva Petrie, Francesco Cappelli, Federico Perfetto, Yousuf Razvi, Aldostefano Porcari, Sriram Ravichandran, Adam Ioannou, Joshua Bomsztyk, Alessia Argirò, Costanza Gaudio, Elisabetta Antonioli, Alessandro Barilaro, Marco Delsante, Vittorio Di Maso, Maria G. Chiappini, Olabisi Ogunbiyi, Oliver C. Cohen, Ana Martinez-Naharro, Carol Whelan, Helen J. Lachmann, Ashutosh D. Wechalekar, Federico Alberici, Marianna Fontana, Marco Allinovi, Julian D. Gillmore |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12139 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis
by: Alessia Argirò, et al.
Published: (2025-04-01) -
A retrospective study of isatuximab-pomalidomide-dexamethasone in relapsed/refractory systemic AL amyloidosis
by: Sargam Rachit Vohra, et al.
Published: (2025-07-01) -
Gut microbiota and immunotherapy of renal cell carcinoma
by: Stefano Bibbò, et al.
Published: (2023-12-01) -
When Serum Anti–Phospholipase A2 Receptor Antibodies Go Missing: The Challenge of Predicting Relapse
by: Marco Allinovi, et al.
Published: (2025-06-01) -
Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step
by: Nils Lachmann, et al.
Published: (2017-01-01)